• 0 Citations
  • 0 h-Index
20182018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Federica Gandolfo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles
Primary Progressive Aphasia Medicine & Life Sciences
Dementia Medicine & Life Sciences
Differential Diagnosis Medicine & Life Sciences
Huntington Disease Medicine & Life Sciences
Amyotrophic Lateral Sclerosis Medicine & Life Sciences
Parkinsonian Disorders Medicine & Life Sciences
Neurology Medicine & Life Sciences
Expert Testimony Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2018 2018

Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia

EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Jul 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 9, p. 1470-1486 17 p.

Research output: Contribution to journalReview article

Dementia
Gold
Neurodegenerative Diseases
Population
Decision Making

Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington's disease

EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Jul 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 9, p. 1546-1556 11 p.

Research output: Contribution to journalReview article

Huntington Disease
Amyotrophic Lateral Sclerosis
Neurodegenerative Diseases
Biomarkers
Mutation

Clinical utility of FDG PET in Parkinson's disease and atypical parkinsonism associated with dementia

EANM-EAN Task Force for the recommendation of FDG PET for Dementing Neurodegenerative Disorders, Jul 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 9, p. 1534-1545 12 p.

Research output: Contribution to journalReview article

Parkinsonian Disorders
Parkinson Disease
Dementia
Expert Testimony
Biomarkers

Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia

Bouwman, F., Orini, S., Gandolfo, F., Altomare, D., Festari, C., Agosta, F., Arbizu, J., Drzezga, A., Nestor, P., Nobili, F., Walker, Z., Morbelli, S., Boccardi, M. & F, EANM-EAN. T. F. P., Jul 1 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 9, SI, p. 1526-1533 8 p.

Research output: Contribution to journalArticle

Primary Progressive Aphasia
Differential Diagnosis
Neurology
Atrophy
Nuclear Medicine

Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia

EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Jul 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 9, p. 1526-1533 8 p.

Research output: Contribution to journalArticle

Primary Progressive Aphasia
Differential Diagnosis
Neurology
Atrophy
Nuclear Medicine